LINC00311 Promotes Cancer Stem-like Properties by Targeting MiR-330-5p/TLR4 Pathway in Human Papillary Thyroid Cancer

Overview

Journal Cancer Med

Specialty Oncology

Date 2020 Jan 3

PMID 31894666

Citations 11

Authors

Yu Gao

Fan Wang

Li Zhang

Mei Kang

Liyang Zhu

Lei Xu

Wei Liang

Wei Zhang

Affiliations

Soon will be listed here.

Abstract

Growing evidence has suggested that long noncoding RNAs (lncRNAs) play an essential role in the progression of papillary thyroid cancer (PTC). LncRNA LINC00311 was found to be able to regulate many cellular process in several diseases. However, the function and regulatory mechanism of LINC00311 remains unclear in PTC. In the present study, the results showed that the expression of LINC00311 was upregulated in PTC tissues and cells. Furthermore, knockdown of LINC00311 dramatically suppressed spheroid formation, proliferation, migration, and invasion in PTC cells in vitro. Mechanistic investigations revealed that LINC00311 was negatively correlated with the expression of miR-330-5p, meanwhile, TLR4 was a direct target of miR-330-5p. In addition, rescue assays further determined that LINC00311 contributed to the progression of PTC through regulating TLR4 expression. Taken together, these findings indicated that LINC00311 could promote cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in PTC.

Citing Articles

Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis.

Ji Y, Gu J, Zhang H, Xu H Int J Gen Med. 2023; 16:5703-5718.

PMID: 38077476 PMC: 10710248. DOI: 10.2147/IJGM.S440340.

Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.

Xu T, Zhu C, Song F, Zhang W, Yuan M, Pan Z BMC Cancer. 2023; 23(1):1131.

PMID: 37990304 PMC: 10664293. DOI: 10.1186/s12885-023-11647-y.

Shi Y, Sheng P, Guo M, Chen K, Zhou H, Wu M Front Genet. 2023; 14:1100909.

PMID: 37470034 PMC: 10352785. DOI: 10.3389/fgene.2023.1100909.

Targeting Autophagy in Thyroid Cancer: EMT, Apoptosis, and Cancer Stem Cells.

Holm T, Yeo S, Turner K, Guan J Front Cell Dev Biol. 2022; 10:821855.

PMID: 35846375 PMC: 9277179. DOI: 10.3389/fcell.2022.821855.

MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Papaioannou M, Chorti A, Chatzikyriakidou A, Giannoulis K, Bakkar S, Papavramidis T Front Oncol. 2022; 11:755097.

PMID: 35186709 PMC: 8851242. DOI: 10.3389/fonc.2021.755097.

References

Wang R, Zhao L, Ji L, Bai L, Wen Q . Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Biomed Pharmacother. 2019; 118:109298. DOI: 10.1016/j.biopha.2019.109298. View

Derwahl M . Linking stem cells to thyroid cancer. J Clin Endocrinol Metab. 2011; 96(3):610-3. DOI: 10.1210/jc.2010-2826. View

Giuffrida R, Adamo L, Iannolo G, Vicari L, Giuffrida D, Eramo A . Resistance of papillary thyroid cancer stem cells to chemotherapy. Oncol Lett. 2016; 12(1):687-691. PMC: 4907300. DOI: 10.3892/ol.2016.4666. View

Lim H, Devesa S, Sosa J, Check D, Kitahara C . Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017; 317(13):1338-1348. PMC: 8216772. DOI: 10.1001/jama.2017.2719. View

Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E . Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013; 24(10):2657-2671. DOI: 10.1093/annonc/mdt301. View

Gao Y, Wang F, Zhang L, Kang M, Zhu L, Xu L . LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020; 9(4):1515-1528. PMC: 7013059. DOI: 10.1002/cam4.2815. View

Murugan A, Munirajan A, Alzahrani A . Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer. 2017; 25(2):R59-R82. DOI: 10.1530/ERC-17-0188. View

Sipos J, Mazzaferri E . Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol). 2010; 22(6):395-404. DOI: 10.1016/j.clon.2010.05.004. View

Xu J, Bai J, Zhang X, Lv Y, Gong Y, Liu L . A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 2016; 18(2):236-249. DOI: 10.1093/bib/bbw015. View

10.

Kim H, Koo J . Immunohistochemical Analysis of Cancer Stem Cell Marker Expression in Papillary Thyroid Cancer. Front Endocrinol (Lausanne). 2019; 10:523. PMC: 6688385. DOI: 10.3389/fendo.2019.00523. View

11.

Lin Z, Lu X, Li W, Sun M, Peng M, Yang H . Association of Cancer Stem Cell Markers With Aggressive Tumor Features in Papillary Thyroid Carcinoma. Cancer Control. 2015; 22(4):508-14. DOI: 10.1177/107327481502200418. View

12.

Liu W, Wang Z, Wang C, Ai Z . Long non-coding RNA MIAT promotes papillary thyroid cancer progression through upregulating LASP1. Cancer Cell Int. 2019; 19:194. PMC: 6659215. DOI: 10.1186/s12935-019-0913-z. View

13.

Liu T, You X, Sui J, Shen B, Zhang Y, Zhang X . Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions. J Cell Biochem. 2018; 120(5):7185-7198. DOI: 10.1002/jcb.27993. View

14.

Mattick J, Rinn J . Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol. 2015; 22(1):5-7. DOI: 10.1038/nsmb.2942. View

15.

Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V . Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 2010; 70(21):8874-85. DOI: 10.1158/0008-5472.CAN-10-1994. View

16.

La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F . Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2014; 136(9):2187-95. DOI: 10.1002/ijc.29251. View

17.

Feng X, Dong X, Wu D, Zhao H, Xu C, Li H . Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p. Histol Histopathol. 2019; 35(2):217-224. DOI: 10.14670/HH-18-155. View

18.

Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A . Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 2016; 35(39):5214. DOI: 10.1038/onc.2016.139. View

19.

Capp J . Cancer Stem Cells: From Historical Roots to a New Perspective. J Oncol. 2019; 2019:5189232. PMC: 6594320. DOI: 10.1155/2019/5189232. View

20.

Lei H, Gao Y, Xu X . LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin (Shanghai). 2017; 49(7):588-597. DOI: 10.1093/abbs/gmx047. View